FR2917089B1 - Nouveaux 4-heteroaryl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique. - Google Patents

Nouveaux 4-heteroaryl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.

Info

Publication number
FR2917089B1
FR2917089B1 FR0755473A FR0755473A FR2917089B1 FR 2917089 B1 FR2917089 B1 FR 2917089B1 FR 0755473 A FR0755473 A FR 0755473A FR 0755473 A FR0755473 A FR 0755473A FR 2917089 B1 FR2917089 B1 FR 2917089B1
Authority
FR
France
Prior art keywords
thiones
tyrosinase
cosmetics
heteroaryl
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0755473A
Other languages
English (en)
Other versions
FR2917089A1 (fr
Inventor
Jean Guy Boiteau
Barbuis Corinne Millois
Karine Bouquet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0755473A priority Critical patent/FR2917089B1/fr
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to JP2010510857A priority patent/JP2010529097A/ja
Priority to CN200880018930A priority patent/CN101679388A/zh
Priority to MX2009012714A priority patent/MX2009012714A/es
Priority to EP08805935A priority patent/EP2164845A1/fr
Priority to CA002688237A priority patent/CA2688237A1/fr
Priority to AU2008263667A priority patent/AU2008263667A1/en
Priority to PCT/FR2008/050995 priority patent/WO2008152332A1/fr
Priority to KR1020107000023A priority patent/KR20100028090A/ko
Priority to RU2009149608/04A priority patent/RU2009149608A/ru
Priority to ARP080102387A priority patent/AR066871A1/es
Publication of FR2917089A1 publication Critical patent/FR2917089A1/fr
Application granted granted Critical
Publication of FR2917089B1 publication Critical patent/FR2917089B1/fr
Priority to US12/631,309 priority patent/US7989483B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR0755473A 2007-06-05 2007-06-05 Nouveaux 4-heteroaryl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique. Expired - Fee Related FR2917089B1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR0755473A FR2917089B1 (fr) 2007-06-05 2007-06-05 Nouveaux 4-heteroaryl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.
KR1020107000023A KR20100028090A (ko) 2007-06-05 2008-06-04 티로시나제 억제제로서 사용된 신규한 4-헤테로아릴-이미다졸-2-티온스, 이의 제조 방법 및 인간 의약 및 미용술에서의 이의 용도
MX2009012714A MX2009012714A (es) 2007-06-05 2008-06-04 Nuevas 4-heteroail-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
EP08805935A EP2164845A1 (fr) 2007-06-05 2008-06-04 Nouveaux 4-héteroaryl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procédé de préparation et leur utilisation en médecine humaine ainsi qu'en cosmétique
CA002688237A CA2688237A1 (fr) 2007-06-05 2008-06-04 Nouveaux 4-heteroaryl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
AU2008263667A AU2008263667A1 (en) 2007-06-05 2008-06-04 Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
JP2010510857A JP2010529097A (ja) 2007-06-05 2008-06-04 チロシナーゼ阻害剤としての新規の４−ヘテロアリールイミダゾール−２−チオン、その調製方法ならびにヒトの医薬および化粧品におけるその使用
CN200880018930A CN101679388A (zh) 2007-06-05 2008-06-04 用作酪氨酸酶抑制剂的新型4-杂芳基咪唑-2-硫酮、它们的制备方法和它们在人类药物和化妆品中的用途
RU2009149608/04A RU2009149608A (ru) 2007-06-05 2008-06-04 Новые 4-гетероарилимидазол-2-тионы в качестве ингибиторов тирозиназы, способ их получения и их применение в медицине человека, а также в косметике
PCT/FR2008/050995 WO2008152332A1 (fr) 2007-06-05 2008-06-04 Nouveaux 4-héteroaryl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procédé de préparation et leur utilisation en médecine humaine ainsi qu'en cosmétique
ARP080102387A AR066871A1 (es) 2007-06-05 2008-06-05 4-heteroaril-imidazol-2-tionas inhibidoras de tirosinasa,procedimiento de preparacion, y composiciones farmaceuticas y cosmeticas que las contienen destinadas al tratamiento o prevencion de trastornos pigmentarios.
US12/631,309 US7989483B2 (en) 2007-06-05 2009-12-04 4-heteroarylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0755473A FR2917089B1 (fr) 2007-06-05 2007-06-05 Nouveaux 4-heteroaryl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.

Publications (2)

Publication Number Publication Date
FR2917089A1 FR2917089A1 (fr) 2008-12-12
FR2917089B1 true FR2917089B1 (fr) 2009-07-17

Family

ID=38962668

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0755473A Expired - Fee Related FR2917089B1 (fr) 2007-06-05 2007-06-05 Nouveaux 4-heteroaryl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.

Country Status (12)

Country Link
US (1) US7989483B2 (fr)
EP (1) EP2164845A1 (fr)
JP (1) JP2010529097A (fr)
KR (1) KR20100028090A (fr)
CN (1) CN101679388A (fr)
AR (1) AR066871A1 (fr)
AU (1) AU2008263667A1 (fr)
CA (1) CA2688237A1 (fr)
FR (1) FR2917089B1 (fr)
MX (1) MX2009012714A (fr)
RU (1) RU2009149608A (fr)
WO (1) WO2008152332A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2917087B1 (fr) * 2007-06-05 2012-09-21 Galderma Res & Dev Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.
TWI508950B (zh) * 2014-08-29 2015-11-21 Univ Hungkuang 3-methyl-2-sulfanyl-2,3-dihydro-1H-imidazole-1-carboxylic acid Tertiary butyl ester and its preparation method and use
JP6553961B2 (ja) * 2015-06-25 2019-07-31 花王株式会社 美白剤
CN116854267B (zh) * 2023-09-01 2024-01-02 杭州尚善若水环保科技有限公司 一种用于反渗透膜的阻垢剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4159338A (en) * 1977-02-09 1979-06-26 E. I. Du Pont De Nemours And Company Antiinflammatory-4,5-dicyclic-2-(substituted thio)-imidazoles and their corresponding sulfoxides and sulfones
JPH05124923A (ja) * 1991-04-09 1993-05-21 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
JPH05132422A (ja) * 1991-04-09 1993-05-28 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
US7115748B2 (en) * 2004-12-07 2006-10-03 Allergan, Inc. Method of making imidazole-2-thiones
FR2917087B1 (fr) * 2007-06-05 2012-09-21 Galderma Res & Dev Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.

Also Published As

Publication number Publication date
US7989483B2 (en) 2011-08-02
CA2688237A1 (fr) 2008-12-18
KR20100028090A (ko) 2010-03-11
JP2010529097A (ja) 2010-08-26
WO2008152332A1 (fr) 2008-12-18
AU2008263667A1 (en) 2008-12-18
MX2009012714A (es) 2009-12-08
RU2009149608A (ru) 2011-07-20
AR066871A1 (es) 2009-09-16
EP2164845A1 (fr) 2010-03-24
CN101679388A (zh) 2010-03-24
FR2917089A1 (fr) 2008-12-12
US20100144813A1 (en) 2010-06-10

Similar Documents

Publication Publication Date Title
FR2937972B1 (fr) Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2937973B1 (fr) Modulateurs des recepteurs de la melanocortine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
UA109650C2 (xx) Біс-арилзв'язані арилтриазолони та їх застосування
PH12017502286A1 (en) Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
FR2939136B1 (fr) Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
UA102065C2 (xx) Заміщені 4-арил-1,4-дигідро-1,6-нафтиридинаміди і їх застосування$замещенные 4-арил-1,4-дигидро-1,6-нафтиридинамиды и их применение
EA201291336A1 (ru) Замещенные 5-фтор-1н-пиразолопиридины и их применение
EP2921177A3 (fr) Immunoglobulines à double domaine variable et utilisations de celles-ci
WO2008139122A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
TW200833330A (en) Substituted dihydropyrazolones and their use
EP2528603A4 (fr) Compositions pharmaceutiques pour le traitement de la douleur et d'autres indications
WO2012088266A3 (fr) Imidazopyridazines et benzimidazoles substitués en tant qu'inhibiteurs de fgfr3
WO2007038459A3 (fr) Composes de carboxyamine et leurs methodes d'utilisation
PH12018500641A1 (en) Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
EP2619356A4 (fr) Préparation riche en matrices fibreuses à base de facteurs de croissance pour le génie tissulaire, la libération de facteurs de croissance et la cicatrisation
BR112013013167A8 (pt) inibidores de bromodomínio e usos dos mesmos
FR2958163B1 (fr) Preparation issue d'une culture in vitro de cellules dedifferencieres non elicitees d'arganier, leur utilisation pour le traitement du vieillissement cutane, de l'inflammation et de la cicatrisation, et leur obtention.
WO2007105015A3 (fr) DÉRIVES D'ACIDE 18ß-GLYCYRRHETINIQUE
EP2253305A3 (fr) Traitement de la peau pour affiner les pores
FR2917087B1 (fr) Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.
FR2935380B1 (fr) Nouveaux composes hexafluoro-2-biphenyl-isopropanol, modulateurs des recepteurs de type lxrs, leur procede de preparation et leur application comme medicaments en medecine humaine ou veterinaire ainsi qu'en cosmetique.
FR2947268B1 (fr) Nouveaux composes benzene-sulfonamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
FR2937868B1 (fr) Composes antagonistes des recepteurs de la melanocortine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
DE102009018133A8 (de) Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen
FR2944794B1 (fr) Procede de preparation d'oligomeres de glycoside de flavonoide et utilisation en cosmetique.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140228